Abstract
Though polycystic liver disease (PCLD) has historically been considered a contraindication to TIPS, we present a case where technically successful shunt creation was achieved without the need for modification of the standard TIPS procedure, as was required in a previous report.
Similar content being viewed by others
References
Kerlan RK, LaBerge JM, Gordon RL, Ring EJ (1995) Transjugular intrahepatic portosystemic shunts: Current status. AJR 164:1059–1066
Spillane RM, Kaufman JA, Powelson J, Geller SC, Waltman AC (1997) Successful transjugular intrahepatic portosystemic shunt creation in a patient with polycystic liver disease. AJR 169:1542–1544
Brown RS, Lake JR (1997) Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications. Adv Int Med 42:485–504
Delguercio E, Greco J, Kim KE, Chinitz J, Schwartz C (1973) Esophageal varices in adult patients with polycystic kidney and liver disease. N Engl J Med 289:678–679
Katzen NG (1964) Fatal hepatic polycystic disease. (letter) Br Med J 28:839–840
Belcher HE, Wright PD, Rose JDG (1996) Case report: Variceal hemorrhage due to polycystic liver treated by transhepatic intervention. Clin Radiol 51:732–734
Saxon RR, Timmermans HA, Uchida BT, Petersen BD, Benne KG, Rabkin J, Keller FS (1997) Stent-grafts for revision of TIPS stenoses and occlusion: A clinical pilot study. J Vase Interv Radiol 8:539–548
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bahramipour, P.F., Festa, S., Biswal, R. et al. Transjugular intrahepatic portosystemic shunt for the treatment of intractable ascites in a patient with polycystic liver disease. Cardiovasc Intervent Radiol 23, 232–234 (2000). https://doi.org/10.1007/s002700010051
Issue Date:
DOI: https://doi.org/10.1007/s002700010051